Requires evidence-based standards for health care pre-authorization

File S09651 ("Requires evidence-based standards for health care pre-authorization") is before the New York Legislature and has not been decided. Latest step (April 27, 2026): Senate Floor Calendar.

New York file S09651, before the New York Legislature. Still to be decided as of 2026-04-27.

What it does

Faster access to prescribed drugs and treatments you need Insurers must use evidence-based clinical criteria to approve or deny pre-authorization requests, reducing delays when your doctor prescribes a drug or service that requires insurance sign-off first.

The bigger picture

Standardized review processes across insurers lower administrative friction Requiring peer-reviewed clinical standards instead of proprietary insurer criteria may reduce variation in approval decisions across health plans and shift administrative costs from providers back to insurers.

What to watch

Insurers may argue standards limit their cost-control tools Insurance industry warns that mandating evidence-based criteria could constrain their ability to manage drug formularies and utilization, potentially raising premiums if cost-control mechanisms are narrowed.

Official summary

Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.

How they voted

Yes (15)

Read the official record for S09651

See everything up for a vote · This week in New York · See what we have filed with the clerk